Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com
Your Definitive Forum for Fast-Tracking Novel Lipid-Based Carrier Systems for Extrahepatic & Next-Generation Genetic Payloads Towards Patients
2023 was the landmark of the year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returned to unite 140+ Delivery, Formulation, Engineering & Analytical leaders all racing to uncover the potential of lipid-carrier system properties.
This was your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for targeted & extrahepatic delivery, overcoming the limitations of conventional LNPs.
Providing a complete picture of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals, silicon stabilized hybrid lipid nanoparticles and beyond, stay ahead of the curve alongside industry’s thought-leaders to progress your candidates to the clinic with optimized payload safety and efficacy.
You could have joined AstraZeneca, Beam Therapeutics, Genentech, Novartis, Pfizer and more to expedite the next-generation of lipid-based nanoparticle delivery systems closer to patients this August!



2023 World-Class Speaker Faculty Included:





Jeffrey Clogston
Principal Scientist
Nanotechnology Characterization Laboratory, National Cancer Institute, Leidos Biomedical Research

What You Missed at the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit:
Hear From Our 2022 Attendees:
“Excellent event that is poised for massive growth.”
Principal Scientist, Merck & Co


“Great opportunity to learn in a diverse environment and with brilliant minds!”
Senior Scientist, Eli Lilly
“Congratulations event organizers for successfully conducting the 1st Next Gen Lipid-Based Nanoparticles Delivery Summit, keep going with more meetings with additional speakers from well established research and organizations in the field.”
Oligonucleotide Discovery Professional, Janssen
